The ROE as of September 2024 (TTM) for Takeda Pharmaceutical Company Limited (TAK) is 2.08%

According to Takeda Pharmaceutical Company Limited’s latest financial reports and current stock price. The company's current ROE is 2.08%. This represents a change of 301.45% compared to the average of 0.52% of the last 4 quarters.

Takeda Pharmaceutical Company Limited (TAK) Historical ROE (quarterly & annually)

How has TAK ROE performed in the past?

The mean historical ROE of Takeda Pharmaceutical Company Limited over the last ten years is 3.41%. The current 2.08% ROE has changed -39.03% with respect to the historical average. Over the past ten years (40 quarters), TAK's ROE was at its highest in in the June 2017 quarter at 7.19%. The ROE was at its lowest in in the March 2015 quarter at -10.55%.

Takeda Pharmaceutical Company Limited (TAK) ROE by Quarter and Year

Discovering the peaks and valleys of Takeda Pharmaceutical Company Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Takeda Pharmaceutical Company Limited (TAK) Average ROE

How has TAK ROE performed in the past?

The current ROE of Takeda Pharmaceutical Company Limited (TAK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Takeda Pharmaceutical Company Limited (TAK) ROE vs. Peers

How is TAK’s ROE compared to its peers?

Takeda Pharmaceutical Company Limited’s ROE is greater than Viatris Inc. (-3.20%), greater than Elanco Animal Health Incorporated (-20.61%), less than Zoetis Inc. (46.65%), greater than Emergent BioSolutions Inc. (-98.39%), less than Prestige Consumer Healthcare Inc. (12.68%), less than Amphastar Pharmaceuticals, Inc. (25.42%), greater than Deciphera Pharmaceuticals, Inc. (-52.42%), less than Pacira BioSciences, Inc. (7.32%), less than Collegium Pharmaceutical, Inc. (49.14%), less than SIGA Technologies, Inc. (51.39%), less than Indivior PLC (812.66%), less than Esperion Therapeutics, Inc. (26.20%), greater than Catalent, Inc. (-26.99%), greater than Evotec SE (-15.59%), less than Eagle Pharmaceuticals, Inc. (4.41%), less than Neurocrine Biosciences, Inc. (14.86%), less than Phibro Animal Health Corporation (0.91%), greater than Teva Pharmaceutical Industries Limited (-6.77%), less than Haleon plc (6.54%), less than Bausch Health Companies Inc. (3.27%),

Build a custom stock screener for Takeda Pharmaceutical Company Limited (TAK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Takeda Pharmaceutical Company Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Takeda Pharmaceutical Company Limited (TAK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Takeda Pharmaceutical Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.